Facing Your Fears Therapy for ASD with Intellectual Disability
(FYF:ASD/ID Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help adolescents with autism spectrum disorder (ASD) and intellectual disability (ID) who experience significant anxiety. Researchers are testing a therapy called "Facing Your Fears," designed to reduce anxiety and improve coping skills in teens with ASD/ID. Participants will be randomly assigned to either start this therapy immediately or continue their usual treatment before switching to the therapy. The study seeks teens aged 12-18 with ASD/ID who have noticeable anxiety symptoms. As an unphased trial, it offers participants the opportunity to access potentially beneficial therapy tailored to their needs.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this cognitive behavioral intervention is safe for adolescents with ASD and intellectual disability?
Research shows that the Facing Your Fears (FYF) therapy has been adapted and tested for teenagers with Autism Spectrum Disorder and Intellectual Disability (ASD/ID). Earlier studies, including one with 23 teens, found that this cognitive behavioral therapy (CBT) approach significantly improved anxiety and mood symptoms. Importantly, these studies did not report any serious side effects, indicating that the treatment is well-tolerated by this group.
This therapy teaches teens how to manage their emotions and develop coping skills tailored to their individual needs. It emphasizes building confidence through strategies like "graded exposure" (gradually facing fears) and encouraging positive self-talk.
Overall, research supports the safety of the FYF program, as it has been specifically designed and tested for this group without any major safety concerns reported.12345Why are researchers excited about this trial?
Researchers are excited about the Facing Your Fears: ASD/ID therapy because it offers a specialized cognitive-behavioral intervention tailored for individuals with Autism Spectrum Disorder (ASD) and intellectual disabilities. Unlike traditional treatments that might not specifically address the unique sensory and regulatory needs of this population, this therapy focuses on developing emotion regulation skills and somatic management techniques. Additionally, it incorporates individualized cognitive strategies and graded exposure, helping participants gradually face their fears. This personalized approach could provide more effective support compared to the standard care options, which often include medications and general behavioral therapies.
What evidence suggests that Facing Your Fears: ASD/ID could be an effective treatment for anxiety in adolescents with ASD and intellectual disability?
Research has shown that the Facing Your Fears (FYF) program, specially adapted for teenagers with Autism Spectrum Disorder (ASD) and intellectual disability (ID), can greatly reduce anxiety. An earlier study with 23 teens demonstrated noticeable improvements in anxiety and mood. In this trial, participants will join different arms, including a Cognitive Behavioral Intervention arm that uses the FYF program. Studies have found that programs like FYF, which use cognitive-behavioral therapy (CBT), effectively lower anxiety in autistic youth. The program helps build skills such as managing emotions, thinking positively, and gradually facing fears. These techniques have proven effective in managing anxiety in this group.16789
Who Is on the Research Team?
Audrey D Blakeley-Smith, Ph.d.
Principal Investigator
University of Colorado, Denver
Are You a Good Fit for This Trial?
This trial is for adolescents aged 12-18 with Autism Spectrum Disorder (ASD) and Intellectual Disability (ID), having an IQ score of 40-70 and significant anxiety symptoms. They must have a confirmed ASD diagnosis, but can't join if they miss more than three sessions, have a primary non-anxiety mental health condition, or exhibit severe irritability.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either FYF:ASD/ID or TAU for 14 weeks
Crossover Treatment
Participants initially in TAU crossover to receive FYF:ASD/ID
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Facing Your Fears: ASD/ID
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor
United States Department of Defense
Collaborator